HAVN Life Sciences

12:35 PM EST - HAVN Life Sciences : Announced it has expanded its supply partnership with Mycotopia Therapies Inc., adding a second supply agreement that covers functional mushrooms, HAVN Life's recently launched natural health products, as well as white label products. Under the existing agreement, HAVN Life will supply naturally-derived psilocybin compounds to Mycotopia, helping to build a distribution channel to U.S.-based universities, researchers and companies. The Expanded Supply Agreement will allow HAVN Life the opportunity to supply Mycotopia Therapies with functional mushrooms, as well as the white label supply and distribution of HAVN's line of natural OTC health products. HAVN Life Sciences shares C.HAVN are trading up one cent at $0.08.

Stocks in Play